Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Antibodies (Basel, Switzerland)|September 24, 2019
Design Principles for Bispecific IgGs, Opportunities and Pitfalls of Artificial Disulfide BondsLilach Vaks, Dana Litvak-Greenfeld, Stav Dror, et al.The International Journal of Biological Markers|December 20, 2012
Increased expression of CD24 in nonmelanoma skin cancerEhud Miller, Shiran Shapira, Eyal Gur, et al.Journal of Extracellular Vesicles|March 13, 2026
Reduced Mortality in COVID-19 Patients Treated With Inhaled Extracellular Vesicles Expressing CD24Shiran Shapira, Guy Vishnevsky, Hadas Yaakobi, et al.International Journal of Cancer|October 1, 2015
The APC I1307K allele conveys a significant increased risk for cancerAri Leshno, Shiran Shapira, Eliezer Liberman, et al.Therapeutic Advances in Gastroenterology|December 25, 2010
Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in ratsIlan Aroch, Sarah Kraus, Inna Naumov, et al.Journal of Personalized Medicine|September 28, 2021
Predictors of the CD24/CD11b Biomarker among Healthy SubjectsShiran Shapira, Gal Aiger, Amitay Ohayon, et al.Biomedicines|September 28, 2023
Inhaled Exosomes Genetically Manipulated to Overexpress CD24 (EXO-CD24) as a Compassionate Use in Severe ARDS PatientsOrr Green, Gil Shenberg, Roni Baruch, et al.Cancer Immunology Research|January 23, 2019
Activated Eosinophils Exert Antitumorigenic Activities in Colorectal CancerHadar Reichman, Michal Itan, Perri Rozenberg, et al.Oncogene|May 7, 2021
Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cellsShiran Shapira, Eynat Finkelshtein, Dina Kazanov, et al.Journal of Personalized Medicine|August 27, 2021
Feasibly of CD24/CD11b as a Screening Test for Hematological MalignanciesShiran Shapira, Dina Kazanov, Fatin Mdah, et al.Pageof 5